Advertisement
Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Novo Nordisk to Acquire Cardior for up to €1.025b (2024-03-25)
Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is... - Tricares Appoints Ahmed Elmouelhi as CEO (2024-03-25)
TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO). In conjunction with this, a... - Angelini Ventures Adds €7m to Series C of Nouscom (2024-03-21)
> Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing round > Financing will enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinic... - Cure51 Raises €15m Seed Round Led by Sofinnova Partners (2024-03-20)
> Fundraise led by Sofinnova Partners, with participation from Hitachi Ventures GmbH, Life Extension Ventures, Xavier Niel, and Olivier Pomel, CEO, and co-founder of Datadog > Principal investigators included world-renowned oncology centers such as Gustave Rouss... - Medios to Acquire Ceban Pharma for €259.2m in Cash & Shares (2024-03-18)
Important first step in building the leading European Specialty Pharma platform – Mid-term targets to be reached already in 2025 Medios, the leading provider of Specialty Pharma Solutions in Germany, today announced the acquisition of Ceban Pharmaceuticals B... - Tubulis Closes €128m Series B2 & to Establish US Subsidiary (2024-03-14)
> Financing round co-led by EQT Life Sciences and Nextech Invest¹, with participation from current and new leading global biotechnology investors > Proceeds will support clinical evaluation of lead solid tumor ADC candidates, TUB-030 and TUB-040, further techn... - Alithea Genomics Closes CHF 2.8m Seed Financing Extension (2024-03-14)
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a C... - Ricoh Licenses CRISPR/Cas9 from ERS Genomics (2024-03-13)
CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model Ricoh Company, Ltd. today announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited (“ERS Genomics”) for access to ... - Mapp Biopharmaceutical to Use ProBioGen’s GlymaxX Technology (2024-03-13)
ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting... - Mahana Therapeutics Acquires HiDoc Technologies (Cara Care) (2024-03-12)
> Acquisition adds four digital treatment programs targeting significant populations to Mahana’s growing digestive health portfolio > Combined company now has global reach with Cara Care’s IBS program currently being prescribed and reimbursed in Germany? ...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top